Healthcare - Biotechnology - NASDAQ - US
$ 8.78
-3.41 %
$ 600 M
Market Cap
-1.53
P/E
BALANCE SHEET
414 M
ASSETS
487 M
LIABILITIES
-72.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Phathom Pharmaceuticals, Inc.
| Current Assets | 397 M |
| Cash & Short-Term Investments | 381 M |
| Receivables | 1.64 M |
| Other Current Assets | 14.4 M |
| Non-Current Assets | 16.4 M |
| Long-Term Investments | 0 |
| PP&E | 3.62 M |
| Other Non-Current Assets | 12.8 M |
| Current Liabilities | 38.8 M |
| Accounts Payable | 12.6 M |
| Short-Term Debt | 726 K |
| Other Current Liabilities | 25.5 M |
| Non-Current Liabilities | 448 M |
| Long-Term Debt | 138 M |
| Other Non-Current Liabilities | 310 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 381.4 | 155.4 | 183.3 | 287.5 | 243.8 | 0.9 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.6 | 0 | 0 | 82 K | 0 | 0 |
| Inventory | 1.2 | 0 | 0 | 82 K | 0 | 0 |
| Other Current Assets | 13.2 | 10.3 | 6.5 | 7.7 | 23.7 | 4 K |
| Total Current Assets | 397.4 | 160.5 | 186.5 | 291.4 | 255.6 | 0.9 |
| PP&E | 3.6 | 3.5 | 2.6 | 3.4 | 1.4 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.5 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 12.8 | 0.3 | 0.3 | 0.4 | 0.2 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 413.8 | 164.8 | 189.4 | 295.1 | 257.2 | 0.9 |
| LIABILITIES | ||||||
| Accounts Payable | 12.6 | 10.0 | 5.2 | 16.8 | 0.7 | 55 K |
| Short Term Debt | 0.7 | 1.4 | 1.0 | 8.3 | 0.3 | 1.9 |
| Other Current Liabilities | 25.5 | 14.8 | 12.8 | 30.4 | 2.7 | 0.2 |
| Total Current Liabilities | 38.8 | 26.2 | 18.9 | 55.5 | 3.7 | 2.2 |
| Long Term Debt | 138.3 | 96.4 | 90.9 | 41.2 | 23.4 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 309.5 | 117.0 | 7.5 | 4.1 | 2.1 | 0 |
| Total Liabilities | 486.6 | 239.6 | 117.3 | 100.8 | 29.2 | 2.2 |
| EQUITY | ||||||
| Common Stock | 5 K | 3 K | 3 K | 3 K | 2 K | 0 |
| Retained Earnings | (928.7) | (727.1) | (529.4) | (385.5) | (256.4) | (1.3) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (72.8) | (74.8) | 72.2 | 194.3 | 228.0 | (1.3) |
| Total Liabilities and Equity | 413.8 | 164.8 | 189.4 | 295.1 | 257.2 | 0.9 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 51.3 | 39.1 | 37.0 | 33.2 | 24.7 | 8.6 |